MEDA PHARMACEUTICALS INC. is the U.S. subsidiary of Meda AB. Meda is an international specialty pharma company that is fully represented in Europe and the US through its own sales organizations in more than 50 countries.
Meda’s products are sold in about 120 countries, and where it lacks a sales organization, it markets and sells its products via agents and other pharmaceutical companies.
Headquarters of the Group’s parent company—Meda AB—is in Solna, outside of Stockholm, Sweden. Meda’s shares are listed on the NASDAQ OMX Nordic Exchange in Stockholm.
Find out more about Meda AB by visiting www.meda.se.